Clinical Trial Update: Gemcitabine for Marginal Zone Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gemcitabine for marginal zone lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marginal Zone Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Asan Medical Center | Conditions: Non-Hodgkin's Lymphoma, Marginal Zone Lymphoma | Phase 2 | Status: TERMINATED